» Articles » PMID: 37890099

Point Mutations in RyR2 Ca2+-binding Residues of Human Cardiomyocytes Cause Cellular Remodelling of Cardiac Excitation Contraction-coupling

Overview
Journal Cardiovasc Res
Date 2023 Oct 27
PMID 37890099
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: CRISPR/Cas9 gene edits of cardiac ryanodine receptor (RyR2) in human-induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) provide a novel platform for introducing mutations in RyR2 Ca2+-binding residues and examining the resulting excitation contraction (EC)-coupling remodelling consequences.

Methods And Results: Ca2+-signalling phenotypes of mutations in RyR2 Ca2+-binding site residues associated with cardiac arrhythmia (RyR2-Q3925E) or not proven to cause cardiac pathology (RyR2-E3848A) were determined using ICa- and caffeine-triggered Ca2+ releases in voltage-clamped and total internal reflection fluorescence-imaged wild type and mutant cardiomyocytes infected with sarcoplasmic reticulum (SR)-targeted ER-GCaMP6 probe. (i) ICa- and caffeine-triggered Fura-2 or ER-GCaMP6 signals were suppressed, even when ICa was significantly enhanced in Q3925E and E3848A mutant cardiomyocytes; (ii) spontaneous beating (Fura-2 Ca2+ transients) persisted in mutant cells without the SR-release signals; (iii) while 5-20 mM caffeine failed to trigger Ca2+-release in voltage-clamped mutant cells, only ∼20% to ∼70% of intact myocytes responded respectively to caffeine; (iv) and 20 mM caffeine transients, however, activated slowly, were delayed, and variably suppressed by 2-APB, FCCP, or ruthenium red.

Conclusion: Mutating RyR2 Ca2+-binding residues, irrespective of their reported pathogenesis, suppressed both ICa- and caffeine-triggered Ca2+ releases, suggesting interaction between Ca2+- and caffeine-binding sites. Enhanced transmembrane calcium influx and remodelling of EC-coupling pathways may underlie the persistence of spontaneous beating in Ca2+-induced Ca2+ release-suppressed mutant myocytes.

Citing Articles

Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity.

Devilee L, Salama A, Miller J, Reid J, Ou Q, Baraka N NPJ Regen Med. 2025; 10(1):1.

PMID: 39799185 PMC: 11724930. DOI: 10.1038/s41536-025-00389-z.


Attempts to Create Transgenic Mice Carrying the Q3924E Mutation in RyR2 Ca Binding Site.

Zhang X, Tang F, Trouten A, Morad M Cells. 2025; 13(24.

PMID: 39768143 PMC: 11674951. DOI: 10.3390/cells13242051.


Can cardiomyocytes bypass the 'Ca2+-induced Ca2+-release' mechanism?.

Luo S, Benitah J, Gomez A Cardiovasc Res. 2024; 120(1):6-9.

PMID: 38198240 PMC: 10898926. DOI: 10.1093/cvr/cvad193.

References
1.
Xu S, Zeng F, Boulay G, Grimm C, Harteneck C, Beech D . Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. Br J Pharmacol. 2005; 145(4):405-14. PMC: 1576154. DOI: 10.1038/sj.bjp.0706197. View

2.
Togashi K, Inada H, Tominaga M . Inhibition of the transient receptor potential cation channel TRPM2 by 2-aminoethoxydiphenyl borate (2-APB). Br J Pharmacol. 2008; 153(6):1324-30. PMC: 2275460. DOI: 10.1038/sj.bjp.0707675. View

3.
Morad M, Zhang X . Mechanisms of spontaneous pacing: sinoatrial nodal cells, neonatal cardiomyocytes, and human stem cell derived cardiomyocytes. Can J Physiol Pharmacol. 2017; 95(10):1100-1107. DOI: 10.1139/cjpp-2016-0743. View

4.
Li Y, Wei J, Guo W, Sun B, Estillore J, Wang R . Human RyR2 (Ryanodine Receptor 2) Loss-of-Function Mutations: Clinical Phenotypes and In Vitro Characterization. Circ Arrhythm Electrophysiol. 2021; 14(9):e010013. DOI: 10.1161/CIRCEP.121.010013. View

5.
Kondo R, Weiss J, Goldhaber J . Putative ryanodine receptors in the sarcolemma of ventricular myocytes. Pflugers Arch. 2000; 440(1):125-31. DOI: 10.1007/s004240000259. View